Boehnke KF - Search Results

1

Trends in U.S. Medical Cannabis Registrations, Authorizing Clinicians, and Reasons for Use From 2020 to 2022.

Boehnke KF, Sinclair R, Gordon F, Hosanagar A, Roehler DR, Smith T, Hoots B. Boehnke KF, et al. Ann Intern Med. 2024 Apr;177(4):458-466. doi: 10.7326/M23-2811. Epub 2024 Apr 9. Ann Intern Med. 2024. PMID: 38588545

2

U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020 : An Observational Study.

Boehnke KF, Dean O, Haffajee RL, Hosanagar A. Boehnke KF, et al. Ann Intern Med. 2022 Jul;175(7):945-951. doi: 10.7326/M22-0217. Epub 2022 Jun 14. Ann Intern Med. 2022. PMID: 35696691 Free PMC article.

3

Medicinal Cannabis Use for Rheumatic Conditions in the US Versus Canada: Rationale for Use and Patient-Health Care Provider Interactions.

Boehnke KF, Martel MO, Smith T, He Y, Bergmans RS, Kruger DJ, Andwele M, Bevan S, Williams DA, Fitzcharles MA. Boehnke KF, et al. ACR Open Rheumatol. 2023 Sep;5(9):443-453. doi: 10.1002/acr2.11592. Epub 2023 Jul 31. ACR Open Rheumatol. 2023. PMID: 37519131 Free PMC article.

4

Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults.

Wilson-Poe AR, Smith T, Elliott MR, Kruger DJ, Boehnke KF. Wilson-Poe AR, et al. Among authors: boehnke kf. JAMA Netw Open. 2023 Dec 1;6(12):e2347373. doi: 10.1001/jamanetworkopen.2023.47373. JAMA Netw Open. 2023. PMID: 38091045 Free PMC article.

5

Risk Factors for the Development of Multisite Pain in Children.

Kaplan CM, Schrepf A, Boehnke KF, He Y, Smith T, Williams DA, Bergmans R, Voepel-Lewis T, Hassett AL, Harris RE, Clauw DJ, Beltz AM, Harte SE. Kaplan CM, et al. Among authors: boehnke kf. Clin J Pain. 2023 Nov 1;39(11):588-594. doi: 10.1097/AJP.0000000000001148. Clin J Pain. 2023. PMID: 37440345

6

Brief Commentary: Cannabinoid Dosing for Chronic Pain Management.

Boehnke KF, Clauw DJ. Boehnke KF, et al. Ann Intern Med. 2019 Jan 15;170(2):118. doi: 10.7326/M18-2972. Epub 2019 Jan 8. Ann Intern Med. 2019. PMID: 30615778 No abstract available.

7

Cannabinoids for Chronic Pain: Translating Systematic Review Findings Into Clinical Action.

Boehnke KF, Clauw DJ. Boehnke KF, et al. Ann Intern Med. 2022 Aug;175(8):1191-1192. doi: 10.7326/M22-1512. Epub 2022 Jun 7. Ann Intern Med. 2022. PMID: 35667063 No abstract available.

8

The Association of Cannabis Use After Discharge From Surgery With Opioid Consumption and Patient-reported Outcomes.

Bicket MC, Ladha KS, Boehnke KF, Lai Y, Gunaseelan V, Waljee JF, Englesbe M, Brummett CM. Bicket MC, et al. Among authors: boehnke kf. Ann Surg. 2024 Mar 1;279(3):437-442. doi: 10.1097/SLA.0000000000006085. Epub 2023 Aug 28. Ann Surg. 2024. PMID: 37638417

9

Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain.

Boehnke KF, Litinas E, Clauw DJ. Boehnke KF, et al. J Pain. 2016 Jun;17(6):739-44. doi: 10.1016/j.jpain.2016.03.002. Epub 2016 Mar 19. J Pain. 2016. PMID: 27001005 Free article.

10

Treatment of Fibromyalgia in the 21st Century.

Silveira MJ, Boehnke KF, Clauw D. Silveira MJ, et al. Among authors: boehnke kf. JAMA Intern Med. 2021 Jul 1;181(7):1011. doi: 10.1001/jamainternmed.2020.9276. JAMA Intern Med. 2021. PMID: 33683305 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page